VNRX — VOLITIONRX LTD
—
NYSE ·
Health Care ·
Life Sciences Tools & Services ·
CIK 93314 ·
Last close
$1.37
Market Cap
$15.87M
52W High
$6.00
52W Low
$1.30
ADV30
361,172
Next earnings
2026-08-13
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 985,076 | — | -5,228,321 | -6,664,774 | 9,036,483 | 3,102,817 | 42,396,412 |
| Dec 2025 | 447,034 | — | -4,731,280 | -6,270,832 | 6,901,227 | 1,117,028 | 42,494,038 |
| Sep 2025 | 627,277 | — | -4,868,806 | -5,378,358 | 6,448,885 | 199,407 | 42,398,447 |
| Jun 2025 | 406,688 | — | -6,221,816 | -6,284,078 | 8,704,790 | 2,255,996 | 41,803,112 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-20,665,448
Investing CF
$-96,964
Financing CF
$21,041,954
CapEx
$-98,772
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-4.29
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-259,566,144
Inventory
—
Receivables
$252,242
ST Investments
—
EBIT TTM
$-21,761,613
Pretax Income TTM
$-24,730,259
Interest Exp TTM
$2,968,646
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,466,075
EBITDA
$-20,626,568
Free Cash Flow
$-9,201,276
Enterprise Value
$18,877,244
Total Cash
$3,102,817
Total Debt
$11,702,884
Shares Out
11,587,191
Trailing EPS
$-4.25
Book Value
$-5.45
ROE
—
ROA
-153.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,727,384 | -21,222,056 | -23,357,027 | 6,901,227 | 42,494,038 | — | -19,683,334 |
| Dec 2024 | 1,233,511 | -26,921,602 | -26,967,836 | 9,399,523 | 35,507,259 | — | -25,893,624 |
| Dec 2023 | 775,302 | -35,773,244 | -35,319,078 | 27,950,498 | 36,662,720 | — | -18,062,999 |
| Dec 2022 | 306,392 | -30,550,647 | -30,268,793 | 18,295,054 | 21,422,016 | — | -15,277,742 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.15
Max Pain — expiry 2026-07-17 (volume-derived — Yahoo OI feed degraded)
max pain strike: $2.50 · spot: $1.37 · call volume: 15 · put volume: 2
Expected Move to 2026-07-17:
±$1.15
(83.94%) —
implied range
$0.22 –
$2.52
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TRIB | TRINITY BIOTECH PLC | $11.74M | $0.58 | — |
| AWHL | Aspira Women's Health Inc. | $24.10M | $0.51 | — |
| NYMXF | NYMOX PHARMACEUTICAL CORP | $10.40M | $0.11 | — |
| QCLS | Q/C TECHNOLOGIES, INC. | $30.31M | $3.86 | — |
| ONMD | OneMedNet Corp | $32.79M | $0.60 | — |
News headlines (Yahoo Finance, 1h cache)
VolitionRx Announces Collaboration with Sysmex
2026-06-17 12:15 · Yahoo
VolitionRx Announces Pricing of $4.6 Million Public Offering
2026-06-07 22:30 · Yahoo
VolitionRx Files New Patent Protecting its Nu.Q® NETs Test for Ebola Triage and Treatment Monitoring
2026-06-03 12:12 · Yahoo
VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets
2026-05-27 12:17 · Yahoo
VolitionRx Limited (VNRX): 7 Best Rated Penny Stocks to Buy According to Wall Street Analysts
2026-05-24 11:49 · Yahoo
VolitionRX Ltd (VNRX) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic ...
2026-05-15 23:02 · Yahoo
VolitionRx Limited Announces First Quarter 2026 Financial Results and Business Update
2026-05-14 20:10 · Yahoo
VolitionRx Limited Schedules First Quarter 2026 Earnings Conference Call and Business Update
2026-05-11 12:19 · Yahoo
VolitionRx Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats
2026-05-06 12:17 · Yahoo
Volition Announces Breakthrough Finger-Prick Detection of Nucleosomes; Expanding Global Market Potential for Sepsis Testing
2026-04-29 12:17 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.